QYR in News
Home > QYR in News > On July 16th Fuxiang Pharmaceuticals cited a fungal protein data analysis report published by QYResearch
On July 16th Fuxiang Pharmaceuticals cited a fungal protein data analysis report published by QYResearch
QYResearch data show that the global fungal protein market size is expected to reach 878 million U.S. dollars in 2029, 2023-2029 CAGR of 18.24%, meat substitutes are the main application scenarios, the market size in 2022 accounted for 93.12%, the current concentration of the overseas market is high, Fuxiang Pharmaceuticals researched its own short-stalked Fusarium, leading the domestic filamentous fungal protein Track, a phase of production capacity is expected to land in the second half of 2024. Commercialization, the company has signed purchase orders with a number of downstream customers, fungal protein volume can be expected.
Source: Sina Finance, Securities Star
More: http://stock.finance.sina.com.cn/stock/go.php/vReport_Show/kind/lastest/rptid/774434785286/index.phtml
http://stock.stockstar.com/report/data_all_issyxpvsywsvquqwptrpr.html
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.